nearmedic.ru
About company
NEARMEDIC will base its pharmaceutical production on Kagocel®, an antiviral drug available over the counter. Construction of the new GMP-tailored manufacturing facility will enable NEARMEDIC to remove Kagocel production from a rented facility and greatly expand manufacturing operations to further strengthen its Russian and the CIS market positions. Kagocel is a compound of an active plant-based gossypol molecule with a nanosized polymer carrier. The joining of this small molecule to a highmolecular-weight polymer-carrier prevents rapid metabolism of the active ingredient in the organism, prolonging the drug’s pharmacological activity and avoiding toxicity. Therein lies its uniqueness. Kagocel elicits the formation of alpha- beta- and gamma-interferons in the human organism. The interferons have highly antiviral activity, effective in treatment and prevention of flu and other acute respiratory infections and in treatment of herpes infections.
